Congenital tracheal defects: embryonic development and animal models by Sher, Zenab Arooj & Liu, Karen Jasmine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.3934/genet.2016.1.60
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Sher, Z. A., & Liu, K. J. (2016). Congenital tracheal defects: embryonic development and animal models. AIMS
Genetics, 3(1). 10.3934/genet.2016.1.60
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
    AIMS Genetics, 3(1): 60-73. 
    DOI: 10.3934/genet.2016.1.60 
    Received 27 February 2016,  
    Accepted 29 March 2016,  
    Published 31 March 2016 
http://www.aimspress.com/journal/Genetics 
 
Review 
Congenital tracheal defects: embryonic development and animal models 
Zenab Arooj Sher and Karen J Liu * 
Department of Craniofacial Development and Stem Cell Biology, King’s College London, Floor 27, 
Tower Wing, Guy’s Hospital Campus, London, SE1 9RT 
* Correspondence: Email: karen.liu@kcl.ac.uk; Tel: +44-(0)20-7188-8035. 
Abstract: Tracheal anomalies are potentially catastrophic congenital defects. As a newborn begins 
to breathe, the trachea needs to maintain an appropriate balance of elasticity and rigidity. If the 
tracheal cartilages are disorganized or structurally weak, the airways can collapse, obstructing 
breathing. Cartilage rings that are too small or too rigid can also obstruct breathing. These anomalies 
are frequently associated with craniofacial syndromes, and, despite the importance, are poorly 
understood. In this review, we summarize the spectrum of pathological phenotypes of the trachea and 
correlate them with the molecular events uncovered in mouse models.  
Keywords: trachea; mouse models; human congenital anomaly; cartilage 
 
1. Introduction 
1.1. The problem: Why is it important to understand tracheal pathology?  
The high morbidity associated with upper airway defects is now an increasingly recognised 
clinical problem. Congenital tracheal defects can be fatal due to intrinsic airway cartilage pathology, 
especially at birth when the neonate must take a first breath. These tracheal defects most commonly 
present as part of a syndrome, such as the tracheal stenosis associated with Apert or Crouzon 
syndromes [1]. Other examples include VACTERL association (vertebral defects, anal atresia, 
cardiac anomalies, tracheoesophageal fistula with oesophageal atresia, radial or renal dysplasia, and 
limb defects) in which the incidence of trachea-oesophageal fistula is well documented [2]. 
Syndromic patients often have other medical problems requiring urgent attention, and the trachea 
may not be prioritised in difficult cases. However, due to the poor quality of life and lack of 
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non-invasive, non-surgical treatment, tracheal development is now an important area of clinical and 
genetic research.  
Most congenital anomalies of the upper respiratory tract are associated with malformed 
cartilage. Thus, it is essential to understand the molecular embryology of the upper respiratory tract, 
particularly the development of the cartilage components [3]. Increasing knowledge of respiratory 
organogenesis will elucidate where and when development is disrupted, providing clues towards 
pathophysiology and eventually directing clinicians towards the development of effective 
intervention. With recent advances in regenerative medicine, tracheal transplants, though currently 
controversial, may provide treatment for some patients [4]. Even though these tracheal transplants 
are groundbreaking, new and can claim to be ‘curative’, the fundamentals of embryological tracheal 
morphogenesis and aetiology of disease processes affecting the trachea remain obscure. A better 
understanding of the underlying developmental events will certainly improve future treatment 
protocols. 
Here, we review the known aspects of tracheal development, describe the spectrum of 
pathology affecting the trachea and then relate the analysis of animal models to the disease 
phenotypes encountered in the clinic. 
1.2. Anatomy, function and development 
The large airways of the respiratory tract are made up of the larynx, trachea and two main 
bronchi (Figure 1a, with key cartilaginous elements depicted in blue). The trachea extends from the 
cricoid cartilage (Cr) of the larynx above, and ends at the carina (Ca), which is a cartilage segment 
demarcating the bifurcation of the trachea into the two bronchi. In humans, it is made up of up to 22 
semi-circular cartilage rings, connected to each other by the annular ligaments (Al), and attached 
dorsally to the trachealis muscle (TM). The trachea is essentially the connection for the passage of 
air between the lungs and the outer environment. Its structure is adapted to maintain the active force 
of inspiration and passive expiration. Aside from breathing mechanics, the inner epithelium of the 
trachea is comprised of adapted ciliated columnar cells which allow the clearing of secretions and 
conditioning of inhaled air. 
The anatomical structure of the mammalian larynx, trachea, and lungs has been unravelled by 
studying serial sections from various stages of development, as in mice [5]. Murine knockout studies 
have uncovered many of the genetic interactions which lead to congenital disease. Mouse models 
have also been developed where mutation of particular genes mimics human anomalies, ultimately 
allowing deeper understanding of human disease processes. Studies have shown in mice that around 
embryonic day (E) 7.5, the larynx and trachea begin development as an out-pouching from the 
ventral side of the foregut, namely the laryngotracheal groove (Figure 2A). Lung buds form at the 
caudal end and the trachea grows by extending downward in length. At E9.5, the ventral tracheal 
endoderm starts separating from the more dorsal endoderm which will form the oesophagus. As 
development proceeds, by E11.5 the two distinct tracheal and oesophageal tubes eventually emerge. 
The trachea then becomes surrounded by mesenchymal cells derived from the splanchnic mesoderm, 
which are committed to the chondrocyte lineage [6]. The committed mesenchymal cells proliferate, 
aggregate, and condense into pre-cartilaginous nodules, which subsequently differentiate into 
chondrocytes forming the semi-circular cartilage rings of the trachea [7]. 
62 
 
AIMS Genetics  Volume 3, Issue 1, 60-73. 
 
Figure 1. Spectrum of pathological phenotoypes of the tracheal cartilages. 
1a) Schematic representation of normal anatomy, frontal view. Cartilages are depicted in 
blue, epithelium in pink and oesophagus/stomach in orange. Oe: oesophagus; Hy: hyoid; 
Th: thyroid cartilage; Cr: cricoid cartilage; Al: annular ligaments; Ca: carina; Br: 
Bronchus; St: stomach.  
1a’) Schematic cross-section through tracheal cartilages. Shown are Oe: oesophageal 
tube; TM: trachealis muscle; RE: respiratory epithelium; TC: tracheal cartilage. 
1b–b’) Depiction of tracheal agenesis showing the absence of the tracheal cartilages 
below the larynx. 
1c–c’) Tracheal malacia results from a weakness in the cartilage rings making the trachea 
prone to collapse. This can be seen as a flattening of the tracheal rings in cross-section (1c’). 
1d–d’) Tracheal stenosis is a narrowing of the tracheal lumen. Rather than the normal 
c-shaped cartilage rings with intervening tissue allowing expansion, in tracheal stenosis 
the cartilage rings are o-shaped, and therefore unable to grow. 
1e–e’) In tracheal cartilaginous sleeve, cartilage rings are fused, leading to a loss of the 
intervening fibrous annular ligaments. 
1f–f’) Tracheo-esophageal fistula occurs when the foregut tube fails to separate into 
trachea and oesophagus. 
Development of the trachea is a complex process, which mirrors the spectrum of tracheal 
pathology encountered in the clinic. Several steps in the morphogenesis of respiratory organs have 
been identified and studied using transgenic mouse models. Although this has increased our 
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understanding of tracheal organogenesis, there are still many aspects of upper airway development 
which are not as well understood. In order to unveil the aetiology of tracheal disease, it has become 
important to define the molecular mechanisms which direct foregut morphogenesis [8]. Much of the 
research into respiratory development has focused on the signalling factors which control branching 
morphogenesis of the lung, and only minimal data has been derived in relation to tracheal 
ontogenesis. The trachea, being a foregut derived organ, similarly develops through a process of 
reciprocal inductive interactions between the endoderm and surrounding mesoderm. Defective 
signalling is thought to be the potential cause of some of the disease presentations seen in clinics. 
The signalling networks guiding the processes of tracheal development and the spectrum of tracheal 
disorders are discussed below. 
1.3. The spectrum of congenital tracheal anomalies encountered in the clinic 
Congenital tracheal defects in humans can range from complete agenesis of the trachea to 
excessive production of cartilage, resulting in stenosis. This review aims to gather and classify 
tracheal disease according to pathophysiology. A number of studies have been discussed which aim 
to consolidate what we know so far about tracheal development. These studies have been carried out 
mainly using the mouse as a model organism.  
Tracheal Atresia/Agenesis (TA): Tracheal agenesis (Figure 1b) is the rarest and most fatal of 
congenital anomalies affecting the trachea. The presentation ranges from complete absence of the 
trachea in tracheal agenesis or a partly atretic tube. The Floyds’ classification system categorizes the 
disease according to anatomical presentation of the tracheal-bronchial tree. When there is tracheal 
atresia in a newborn, the affected neonate fails to take a breath, which is diagnosed as congenital 
high airway obstruction syndrome (CHAOS). Because of the structural defects of the airways, 
intubation and resuscitation is unsuccessful in most, if not all cases. Only around 150 human cases 
have been reported to date, with just one survivor [9]. During delivery of a foetus with CHAOS 
syndrome, the head alone can be initially delivered via a maternal Caesarean section, which then 
allows intubation prior to placental blood flow being cut. This is the ex-utero intrapartum therapy 
(EXIT procedure). However, prognosis still remains poor, as ventilation problems continue due to 
the abnormal structure of the trachea [10]. No causative genes have been identified in humans as of 
yet [11]. However, genetic research on mutant mouse models is now indentifying a number of 
transcription factors which may be important in the pathophysiology of tracheal agenesis. These will 
be discussed below. 
Tracheomalacia: Tracheaomalacia is the most common congenital tracheal defect, with a 
prevalence of 1:1500 children [12]. Malacia refers to dynamic collapsibility of the trachea, due to 
softness of the cartilage (Figure 1c). The affected portion of the trachea is prone to collapse, under 
conditions where extraluminal pressure exceeds the intraluminal pressure, i.e. during inspiration [13]. 
Clinical features include dyspnoea, stridor and cyanosis. Narrowing and collapse of the airway 
results in obstruction, which may be relieved by passing a bronchoscope down the trachea to open it 
again. Prognosis ranges from a very high mortality rate to manageable, with most surviving patients 
requiring prolonged respiratory support via a tracheostomy [14]. Congenital tracheal malacia is often 
associated with Down’s syndrome, Trisomy 9, 11p13 deletion (Wilms/aniridia), 22q11 deletion, 
18–22 translocation, chondrodysplasias, Williams–Campbell syndrome, Di George syndrome, 
CHARGE association, Hunter’s syndrome and Hurler’s syndrome [13]. This anomaly has not been 
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attributed to a single causative gene, although some genetic knockout mouse models have explored 
the aetiology of the defect. 
Tracheal Stenosis: This is a fixed narrowing of the tracheal lumen due to intrinsic cartilaginous 
defects (Figure 1d). It cannot be re-opened by a bronchoscope as opposed to the dynamic collapsible 
‘stenosis’ of tracheomalacia. The epidemiology of tracheal stenosis is unknown, however one study 
has suggested an incidence of 1 in 64,500 births [15]. Tracheal stenosis is associated with 
cardiovascular anomalies such as atrial-septal defects, in around 50% of patients. Frequently, 
cartilage rings are constricted and ‘complete’ at the dorsal end, with an O-shape, rather than the 
normal C-shape (Figure 1d). A rare cause of tracheal stenosis is Tracheobronchopathia 
Osteochondroplastica, a disease in which benign cartilaginous/bony nodules grow in the submucosa, 
and block the airway. Tracheo-oesophageal fistula and tracheal stenosis may also co-exist, so both 
might not be two entirely separate entities in the critically ill patient [14]. 
Tracheal Cartilaginous Sleeve: This is a rare congenital malformation of unknown 
epidemiology, which occurs exclusively in Apert, Goldenhar, Pfeiffers syndrome and Crouzon 
disease—all of which are examples of craniosynostosis syndromes [16-18]. The C-shaped tracheal 
rings are frequently fused together, with a loss of the intervening fibrous tissue (Figure 1e). This 
results in a tubular trachea, which may also be stenotic. The pathophysiology of this defect is unclear, 
although some studies have proposed that there may be a common defect in the development of all 
structures derived from hyaline cartilage. For example, in Apert syndrome there is defective limb 
skeletogenesis as well as cranial suture fusion. The morphology of the tracheal cartilaginous sleeve 
anomaly could mirror the overproduction of cartilage in the cranial sutures in these patients. 
Prognosis is very poor, as mortality rate in patients with a tracheal cartilaginous sleeve plus 
craniosynostosis is up to 90% [18]).  
Tracheo-esophageal fistula (TEF) with or without esophageal atresia (OA): This is a relatively 
common abnormality of the foregut, affecting 1 in 3500 births [19]. The common foregut tube fails 
to separate into the trachea and oesophagus, resulting in an abnormal connection between the two 
(Figure 1f). This may rarely manifest as an isolated TEF, however 87% of have one blind-ended 
oesophagus, and a more distal oesophagus which abnormally connects with the trachea [8]. As with 
most tracheal defects, TEF/OA also usually occurs as part of a genetic syndrome in humans, such as 
the VATER/VACTERL association. Table 1 below highlights some mouse models which also 
exhibit a TEF/OA type phenotype. These studies have been reviewed in Que J et al 2006, so an 
in-depth discussion is not provided here [8]. 
TEF/OA is the most commonly researched defect. Trying to interpret the pathophysiology of 
this condition has led to two main theories of foregut separation. One theory proposes that foregut 
division results from fusion of the lateral ridges of the foregut, starting caudally and elongating 
cranially. The septum thus separates the ventral trachea from the dorsal oesophagus. A more recently 
postulated theory suggests that the respiratory diverticulum develops from the ventral aspect of the 
foregut and continues to elongate caudally as the trachea. The mesenchyme which is in between the 
respiratory and digestive tubes, forms the septum, which is apparently fixed and does not move 
during caudal growth of the trachea [20].  
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Table 1. Congenital tracheal anomalies in mouse models. 
Mouse gene  Tracheal Defect 
 TEF/OA TA TM TS Excess/ 
Distortion 
Reference 
Foxf1
+/−
  
(forkhead transcription factor ) 
x     Mahlapuu et al., (2001) 
Gli2 and Gli3 (Hedgehog pathway) x    x Motoyama et al., (1998) 
Nkx2.1 (Homeodomain transcription 
factor) 
x x    Minoo et al., (1999) 
Noggin (Secreted BMP antagonist) x     Que J et al., (2006) 
Shh (Secreted hedgehog  
family ligand) 
x    x Litingtung et al., (1998) 
Miller LA et al., (2004) 
RAR, RAR2  
(Retinoic acid receptors) 
x    x Mendelsohn et al., (1994) 
BMP4  
(Bone morphogenetic protein4) 
 x    Domyan ET et al., (2011) 
TBX4/TBX5 (T-box transcription 
factors) 
 x    Arora M et al., (2012 
CV2 (BMP pathway)  x    Zakin L et al., (2008) 
Tmem16a (transmembrane protein)   x   Rock J et al., (2008) 
Trps1  
(trichorhino-phalangeal sydrome gene) 
  x   Suemoto H et al., (2007) 
Traf4 (TNF receptor associated factor, 
scaffold protein) 
   x  Regnier, C.H (2002) 
Sox9  
(SRY domain transcription factor) 
    x Park et al., (2010) 
FGF10 (Fibroblast Growth Factor 10)     x Tiozzo C et al., (2009), 
Sala et al., (2011) 
Mek1/Mek2 (kinases)  x    Boucherat et al., (2014) 
TEF usually does not occur as an isolated tracheal defect. The development of TEF commonly 
occurs alongside oesophageal pathophysiology, therefore pointing to a defect in overall foregut 
morphogenesis. Although not separate from tracheal development, the aetiology of TEF/OA involves 
non-cartilage defects of the oesophagus likely due to failure of the complex processes of 
epithelial-to-mesenchymal signalling during embryogenesis. These factors have to be considered 
when discussing tracheal abnormalities, and therefore TEF/OA is excluded from in-depth discussion 
in this review. 
2. Stages of tracheal development in mice  
Tracheal development in mice can be organised into 3 consecutive stages for the purpose of this 
review: specification, outgrowth/proliferation and cartilage condensation. These stages can be used 
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to help explain normal development of the trachea, with an aim to identify time points where 
development is disrupted.  
2.1. Specification 
The initial specification of the respiratory primordium is governed by a number of cellular 
events, which will then allow patterning of the cartilage itself. There are some uncertainties 
surrounding what we know about the genes and factors responsible for commitment of cartilage 
precursor cells to the chondrocyte lineage. Many genetic knock-out studies have revealed the 
function of some genes in the development of the respiratory tree. Several key signalling pathways 
are Hedgehog (Hh), Fibroblast Growth Factors (FGF) and bone morphogenetic protein (BMP), 
detailed below. The earliest requirement appears to be the Hh ligand Sonic Hedgehog, as mutation of 
Shh leads to a loss of the transcription factor Foxf1 and early foregut malformations leading to 
tracheo-esophageal fistula [21].  
Two T-box transcription factors, Tbx4 and Tbx5 are expressed in the mesenchyme of the 
developing foregut, and appear to be important in the initial specification of the trachea. Tbx5 (but 
not Tbx4) is required for the initial specification of the trachea, as its expression is detected as early 
as E9.0, in the laryngotracheal groove [22]. Lack of Tbx5 results in no expression of Nkx2.1, hence 
complete absence of tracheal specification. These data place Tbx5 upstream of Nkx2.1, which was 
classically seen as the earliest marker of respiratory development in mice MinooGuoshanDrum et 
al. [23]. Nkx2.1 is a homeodomain transcription factor which is important for the 
epithelial-mesenchymal interactions required for tracheal development. Its expression in the 
epithelium demarcates the ventral boundary of the anterior foregut, distinguishing pulmonary from 
oesophageal tissue. When Nkx2.1 is knocked out in mice, the resulting phenotype is similar to the 
tracheosophageal fistula anomaly seen in humans. As there is still some development of tracheal 
cartilage rings albeit fused and truncated, it would appear that another gene must be responsible for 
initial specification instead of Nkx2.1, which could be Tbx5. 
The retinoic acid receptor pathway also appears important. Retinoic acid receptors (RARs) are 
expressed in the foregut endoderm of developing mouse embryos. Knocking out the different types 
of retinoic acid receptors in mouse models results in a variety of defects. These range from agenesis 
of the trachea to shortening of the tracheal cartilage leading to developmental abnormalities [24]. As 
the effects are quite severe in nature, the RARs may be important not only for specification, but also 
the maintenance of epithelial to mesenchymal signals during development.  
Epithelial-mesenchymal interactions during tracheal specification: Nkx2.1 is epithelial whereas 
Tbx5 is mesenchymal. It appears that both factors interact with one another to initiate tracheal 
specification. Nkx2.1 mutants show TEF whereas Tbx5 mutants have tracheal agenesis. This is a 
similar phenotype to bone morphogenetic protein receptor 1 and 2 (Bmpr1 and Bmpr2) mutants in 
which lung bud specification occurs, but the ventral foregut fails to acquire tracheal identity. 
Signalling via the BMP-R1 and -R2 receptor proteins is required to initiate tracheal identity, via 
repression of the oesophageal marker Sox2 [25]. Therefore, based on the overall phenotype of the 
two knock out mice models, Tbx5 may be upstream of Nkx2.1 in tracheal specification, and acts in 
parallel with or in the BMP signalling pathway to direct the ventral foregut into a trachea. 
Furthermore, Tbx4 and Tbx5 interact genetically and affect tracheal/bronchial cartilage development 
via Sox9, but independently of the Fgf10 signalling pathway. Tbx4 and Tbx5 heterozygous tracheas 
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have fewer cartilage rings, and further reduction of these genes in the lung-specific Tbx4
+/−
; Tbx5
−/−
 
mutants, leads to severely disrupted tracheal and bronchial rings, as mesenchymal cells fail to 
condense. Downstream targets of Sox9 (Sox2 and Sox6) are also down-regulated in these 
mutants [22]. 
2.2. Outgrowth/proliferation 
Following on from specification, at E11.5–E14.50, the mouse laryngotracheal groove then 
elongates bidirectionally, to produce the larynx above and trachea below, with lung buds at the distal 
end. This process of outgrowth is regulated by cell to cell signalling via the recruitment of 
downstream signalling factors. Tbx4/Tbx5 interact with each other and are upstream of Sox9 during 
chondrogenesis (Figure 2B). This leads into the process of ‘outgrowth’ where downstream targets of 
Tbx4 and Tbx5/Nkx2.1 are required specifically at the time of mesenchymal cell condensation and 
proliferation. At E11.5 and E13.5 both Tbx4 and Tbx5 are expressed throughout the tracheal 
mesenchyme in ventral tracheal cells that also express Sox9. At E15.5, their expression is noted in 
the mesenchyme between the cartilage condensations; this is in a pattern complementary to that of 
Sox9, which is restricted to the condensing mesenchyme of the cartilage rings at this stage [22]. 
Sox9 is a transcription factor which is required for every step of chondrogenesis [7]. It is 
expressed in pre-cartilaginous mesenchymal cells which are committed to the chondrocyte lineage, 
even at the specification stage at E9. Its expression is later detected in the ventral tracheal 
mesenchyme from E11.5, and it becomes segmented at E13.5. This segmented pattern indicates 
where the tracheal cartilage rings will form. The same study has shown that induction of this 
ventral/segmented pattern of expression is dependent on the Sonic Hedgehog (SHH) signalling 
pathway. By knocking out the Shh gene in a mouse model, it can be seen that Sox9 expression is 
disrupted. This loss could be partially rescued when Shh mutant tracheas were explanted and treated 
with Bmp4, leading to some cartilage production. Thus, this places Shh upstream of Bmp4 and sox9 
in tracheal chondrogenesis (Figure 2B). 
Sonic Hedgehog signalling is required in the epithelium to initiate tracheal chondrogenesis: 
The Sonic Hedgehog (SHH) ligand is secreted by the endodermal epithelium (Figure 2B). The SHH 
ligand binds to Patched1 (Ptc1), which is expressed in the pre-cartilaginous condensations of the 
trachea. The Shh null mutant is not viable and dies postnatally, due to severe developmental defects. 
These include a single tracheo-oesophageal remnant, devoid of cartilage [26]. The mutants have 
incomplete, misaligned and constricted rings. In the null mouse there is agenesis, and expressing 
SHH in the SHH rescue mouse does not rescue the defects. Deletion between E8 and 12.5 causes 
tracheal cartilage abnormalities, but no effects are seen after E12.5. Furthermore, adding SHH to 
explants does not result in rescuing the defects. Therefore, a major role for SHH in tracheal 
development may be that it is required locally for the induction of cartilage condensations, via 
epithelial to mesenchymal signalling [26]. Consistent with this, Shh appears necessary to initiate and 
maintain the ventral-specific expression of Sox9 in the tracheal mesenchyme. Furthermore, the Gli 
proteins, the downstream effectors of Hedgehog signalling, are also expressed in the tracheal 
mesenchyme. Gli2/3 null mutants lack the tracheal primordium at E9.5, and the Gli2
−/−
; Gli3
−/+
 
mutants have TEF [27]. Mutations in GLI3 are also associated with three human dominant genetic 
disorders, Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome (PHS) and postaxial 
polydactyly type A Syndrome. Foregut malformations including lung lobulation defects, tracheal 
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stenosis and tracheo-oesophageal fistula have been observed in some PHS patients [28]. Interestingly, 
in the absence of SHH function, BMP4 and Noggin can partially induce chondrogenesis, suggesting 
that chondrogenic induction is sensitive to relative levels of BMP activity. Taken together, these 
results suggest that both Bmp4 and noggin genes are downstream of Shh, and they can promote 
cartilage formation in trachea through regulation of chondrogenic genes such as Sox9 (Figure 2B). 
 
Figure 2A. Schematized stages of tracheal development from initial specification to 
proliferation/condensation and subsequent differentiation. Fg: foregut; ltg: 
laryngotracheal groove; lb: lung bud; TM: trachealis muscle; RE: respiratory epithelium; 
TC: tracheal cartilage. Figure 2B. Key signals mediating the epithelial-mesenchymal 
interactions necessary for tracheal morphogenesis. Genes identified are correlated 
with the stages depicted in 2A, with the top third showing genes involved in specification 
of the tracheal primordia, the middle third showing cues important for proliferation and 
condensation of the cartilage progenitors, and the bottom third outlining factors 
important in differentiation of the cartilage rings. Direct protein-protein interactions are 
marked by green arrows while indirect interactions are marked with black lines. 
BMP signalling and the outgrowth of the trachea: Signalling through BMP4 is crucial to the 
subsequent outgrowth of the trachea. This is demonstrated by a Bmp4 knock-out mouse model, in 
which the outgrowth stage was affected (Li et al 2008). At E10.5 the BMP conditional knock-out 
mice had a single endodermal tube, as opposed to the two tubes (representing the oesophagus and 
trachea). This tube has oesophageal characteristics, as it stained for the oesophageal marker Pax9 and 
not the respiratory specific marker Nkx2.1 suggesting a tracheal agenesis type of defect in the BMP4 
knock out embryos. It is worth noting that tracheal induction is actually not affected in these BMP4 
knock out mice as there is comparable Nkx2.1 expression in the mutant and wild-type controls at the 
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embryonic stage of initial tracheal specification, E9.25. The results of this study show that there is 
reduced proliferation of epithelial and mesenchymal cells in the foreguts of BMP4 knock-out mice. 
Interestingly, BMPR1a and BMPR1b are both important in maintaining the fate of the ventral foregut, 
via Nkx2.1 (Domyan et al 2011). These studies indicate that while BMP4 is essential for the normal 
outgrowth of the trachea, BMP signalling via these receptors is required earlier, possibly through 
other ligands. Another mouse mutant which lacks a trachea is the CV2 (crossveinless-2) mutant. CV2 
is a feedback inhibitor of the BMP pathway, discovered to genetically interact with BMP4 in 
formation of crossveins in Drosophila wings [29]. Although this gene’s function is less known in 
murine tracheal development, it may be that BMP4 is upstream of CV2 in tracheal development, as 
CV2 has a role in the maintenance of BMP4 gradients during mouse vertebral development (Figure 
2B, middle). Together, this confirms the importance of BMP signalling, via various downstream 
targets, in the outgrowth stage of normal tracheal development. 
2.3. Cartilage differentiation 
Initiation of the cartilage condensation: Sox9 and Col2a1: Sox9 is expressed throughout the 
developing trachea at the stages when cartilage formation occurs, beginning at E9. Induction of the 
cartilage specific collagen gene Col2A1 is Sox9-dependent and its initial expression is detected a day 
later than Sox9. These chondrocytes then proliferate and migrate along the lateral and anterior 
trachea, in a periodic pattern, eventually forming the mature tracheal cartilage rings [3]. The 
expression of Col2A1 is uniform at E12.5, and becomes periodic at E13.5 to E14.5 in the ventral 
mesenchyme of the trachea [30]. FGF10 expression is detected in the tracheal mesenchymal at E12.5 
becoming segmented by E14.5. When Fgf10 is knocked out in mice, the segmented pattern of 
expression is disrupted at E13.5, resulting in shortened and misformed cartilage rings, due to failure 
of the mesenchymal cells to condense [30]. This appears due to reduced proliferation of cells, rather 
than differentiation.  
At E13.5, Shh expression is reduced in the Fgf10 mutant trachea. This reduction in periodic 
expression of ventral Shh in the Fgf10
−/−
 trachea is associated with an absence of periodicity of type 
II collagen expression [30]. This places both FGF10 and Shh upstream of Col2a1 during 
chondrogenesis. These studies also show that Shh is required for a second step, during the 
maintenance of cartilage differentiation. As for FGF10, the level of Shh expression needs to be 
within a critical range for proper patterning of tracheal cartilage indicating that neither SHH nor 
FGF10 alone is sufficient as an instructive signal for cartilage formation, in fact, both are dependent 
on each other, and act via epithelial to mesenchymal signalling on order to produce tracheal cartilage. 
No changes in Bmp4 and Sox9 have been noted in FGF10 mutants. 
3. What have mouse models taught us? 
Tracheomalacia mouse models: The Tmem16a mouse mutant has a malacic airway, in which 
the cartilage ring incompletely forms, with ventral gaps between the segments [31]. The multiple 
cartilaginous rudiments formed along the trachea are the result of abnormal condensations during 
chondrogenesis. Although a defect of this type has not been identified in humans, this study may still 
help increase knowledge of the epithelial to mesenchymal interactions involved in the 
pathophysiology of tracheomalacia. For example, Tmem16a is expressed in the tracheal epithelium, 
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as opposed to most of the other chondrogenic genes discussed above, which are expressed in the 
mesenchyme.  
Trps1 knock-out mice are also reported to have cartilage nodule formation rather than the 
C-shaped rings and appears to regulate chondrocyte proliferation [32]. Trps1 is a causative gene in 
trichorhinophalangeal syndrome, which affects the orofacial cartilages. Trps1 mutation in mice leads 
to respiratory failure at birth due to the malacic airway.  In both examples above, the condensation 
stage or the proliferation stage is affected in tracheal chondrogenesis, which then results in the 
tracheal malacia defect in the mouse models.  
Mouse model for tracheal cartilaginous sleeve: Ordinarily, FGF10 is expressed segmentally in 
the tracheal mesenchyme, in the areas between the presumptive cartilage [30]. FGF10 appears to 
control the periodicity of cartilage rings via SHH [30]. Over-expressing Fgf10 in a mouse model of 
Apert Syndrome caused the TCS type of defect via ectopic expression of Fgfr2b throughout the 
mesenchyme [33]. Another mouse model demonstrating tracheal cartilaginous sleeve is Crouzon 
syndrome, a related craniosynostosis disorder which carries a gain-of-function mutation in 
FGFR2c [17]. Similarly application of FGF18 to cultured mouse tracheas resulted in an increase in 
the cartilage marker Sox9 (Figure 2B bottom) [34]. Thus, both SHH and FGF signalling networks are 
implicated in the overproduction of cartilage in the tracheal cartilaginous sleeve phenotype.  
Mouse model for tracheal stenosis: Traf4, a TNF receptor pathway protein, is an intracellular 
signalling molecule. Traf4 has been shown to be required for normal tracheal development, as raf4 
deficient mice have a stenotic trachea with a reduced diameter. The cartilage is disrupted frontally, 
and segments are laterally fused. As the traf4 gene is expressed throughout the tracheal epithelium, it 
may be that the cartilage defects are a result of abnormal signalling from the epithelium to the 
surrounding mesenchyme [35]. To our knowledge, this is the only single gene model which has the 
tracheal stenosis phenotype.  
4. Conclusions 
This review has highlighted how normal tracheal anatomy can be affected at many stages 
development. The different types of pathology reflect the intricacy in normal development and 
function of respiratory organs. The spectrum of disease suggests that multiple factors are involved in 
tracheal ontogenesis; many of these have been identified, and some important time points in the 
context of murine development have also been identified. Mouse models for each particular 
syndrome or tracheal abnormality can be developed and used to determine what genes are implicated 
in the aberrant development of the trachea.  
We can establish from numerous studies that tracheal development is reliant on signals from the 
developing epithelium to the mesenchyme and vice versa. It is also clear that there is a requisite 
amount and time for the expression of some molecular factors. Some genes are turned on early in the 
initial specification stage, and they can then recruit other factors for subsequent development of the 
airways. By knocking out one gene we can try to establish its specific role, however there is not a 
clear way of knowing the effect on its downstream targets. What we also do not know is the specifics 
of how development goes wrong to produce the defects we see in the clinic. There are also likely to 
be other factors involved; for example, recent studies have shown that the smooth muscles are also 
necessary for cartilage development in the trachea [36]. 
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One further question that arises during the study of congenital tracheal abnormality is whether 
there are any environmental factors involved. Teratogens, such as the injection of adriamycin in rats, 
have been shown to cause tracheal defects such as TEF/OA and tracheal agenesis [37]. Could there 
be some interplay between genetic and environmental factors which cause the syndromes to occur? 
It is difficult to say which are the most important genes, as none of the tracheal defects 
discussed above can be explained by a single gene disorder. Occurring usually as part of sporadic 
syndromes, it is difficult to categorise tracheal defects into a system based on genetic aetiology. It is 
evident that loss of some genes and signalling factors in mice may recreate the tracheal pathology 
that has been encountered in human patients; however, this does not explain what causes the disease 
in the first instance. Abnormal tracheal samples could be stained for genes/proteins known to be 
important in cartilage development and may direct us to the causative process of the disease in 
question. With recent advances in genetic testing and human induced pluripotent stem cells, we now 
have a great opportunity to learn from affected individuals.  
Future Perspectives: Bioengineered windpipes may provide promising evidence of success in 
some patients [38]. The only successful tracheal transplant carried out on a patient using a 
tissue-engineered trachea seeded with autologous epithelial cells and chondrocytes of mesenchymal 
stem-cell-origin is proving successful even at 5 year follow up [4,38]. However, this procedure was 
carried out on a patient who had acquired tracheal disease, of infective origin. The tracheal defects 
discussed in this work are mainly congenital anomalies which often occur as part of a syndrome with 
other accompanying complications. Therefore, it is unclear whether bioengineered organs can play a 
curative role in congenital airway disease. Nevertheless, it is important to be able to understand the 
molecular development of the tracheal cartilages, which can then be applied to the reconstruction of 
tracheal tubes or breathing support devices. 
Acknowledgements 
The authors are funded by grants from the BBSRC and the MRC. We would like to thank 
William Barrell for help with designing the figures. 
Conflict of interest 
All authors declare no conflicts of interest in this paper. 
References 
1. Cohen MM Jr., Kreiborg S (1992) Upper and lower airway compromise in the Apert syndrome. 
Am J Med Genet 44: 90-93. 
2. Kim JH, Kim PCW, Hui C-c (2001) The VACTERL association: lessons from the Sonic 
hedgehog pathway. Clin Genet 59: 306-315. 
3. Elleru RG, Whitsett JA (2004) Potential role of Sox9 in patterning tracheal cartilage ring 
formation in an embryonic mouse model. Arch Otolaryngol Head Neck Surg 130: 732- 736. 
4. Macchiarini P, Jungebluth P, Go T, et al. (2008) Clinical transplantation of a tissue-engineered 
airway. The Lancet 372: 2023-2030. 
5. Kaufman MH (1992) The Atlas of Mouse Development: Academic Press Inc. 512. 
72 
 
AIMS Genetics  Volume 3, Issue 1, 60-73. 
6. Perl AK, Wert SE, Nagy A, et al. (2002) Early restriction of peripheral and proximal cell 
lineages during formation of the lung. Proc Natl Acad Sci U S A 99: 10482-10487. 
7. Park J, Zhang JJ, Moro A, et al. (2010) Regulation of Sox9 by Sonic Hedgehog (Shh) is 
essential for patterning and formation of tracheal cartilage. Dev Dyn 239: 514-526. 
8. Que J, Choi M, Ziel JW, et al. (2006) Morphogenesis of the trachea and esophagus: current 
players and new roles for noggin and Bmps. Differentiation 74: 422-437. 
9. Lim FY, Crombleholme TM, Hedrick HL, et al. (2003) Congenital high airway obstruction 
syndrome: natural history and management. J Pediatr Surg 38: 940-945. 
10. Hirose S, Harrison MR (2003) The ex utero intrapartum treatment (EXIT) procedure. Seminars 
in Neonatology 8: 207-214. 
11. Hirakawa H, Ueno S, Yokoyama S, et al. (2002) Tracheal agenesis: a case report. Tokai J Exp 
Clin Med 27: 1-7. 
12. Masters IB (2009) Congenital airway lesions and lung disease. Pediatr Clin North Am 56: 
227-242. 
13. Austin J, Ali T (2003) Tracheomalacia and bronchomalacia in children: pathophysiology, 
assessment, treatment and anaesthesia management. Paediatric Anaesthesia 13: 3-11. 
14. Burden RJ (1999) Tracheobronchial malacia and stenosis in children in intensive care: 
bronchograms help to predict outcome. Thorax 54: 511-517. 
15. Herrera P, Caldarone C, Forte V, et al. (2007) The current state of congenital tracheal stenosis. 
Pediatr Surg Int 23: 1033-1044. 
16. Noorily MR, Farmer DL, Belenky WM, et al. (1999) Congenital Tracheal Anomalies in the 
Craniosynostosis Syndromes. J Paediatr Surg 34: 1036-1039. 
17. Eswarakumar VP, Horowitz MC, Locklin R, et al. (2004) A gain-of-function mutation of Fgfr2c 
demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci U S A 101: 
12555-12560. 
18. Lertsburapa K, Schroeder JW Jr., Sullivan C (2010) Tracheal cartilaginous sleeve in patients 
with craniosynostosis syndromes: a meta-analysis. J Pediatr Surg 45: 1438-1444. 
19. Ioannides AS, Massa V, Ferraro E, et al. (2010) Foregut separation and tracheo-oesophageal 
malformations: the role of tracheal outgrowth, dorso-ventral patterning and programmed cell 
death. Dev Biol 337: 351-362. 
20. Merei JM, Hutson JM (2002) Embryogenesis of tracheo esophageal anomalies: a review. 
Pediatr Surg Int 18: 319-326. 
21. Mahlapuu M, Enerback S, Carlsson P (2001) Haploinsufficiency of the forkhead gene Foxf1, a 
target for sonic hedgehog signaling, causes lung and foregut malformations. Development 128: 
2397-2406. 
22. Arora R, Metzger RJ, Papaioannou VE (2012) Multiple roles and interactions of Tbx4 and Tbx5 
in development of the respiratory system. PLoS Genet 8: e1002866. 
23. Minoo P, Guoshan S, Drum H, et al. (1999) Defects in tracheoesophageal and lung 
morphogenesis in Nkx2.1 (−/−) mouse embryos. Developmental Biology 209: 60-71. 
24. Mendelsohn C, Lohnes D, Decimo D, et al. (1994) Function of the retinoic acid receptors 
(RARs) during development (II). Multiple abnormalities at various stages of organogenesis in 
RAR double mutants. Development 120: 2749-2771. 
25. Domyan ET, Ferretti E, Throckmorton K, et al. (2011) Signaling through BMP receptors 
promotes respiratory identity in the foregut via repression of Sox2. Development 138: 971-981. 
73 
 
AIMS Genetics  Volume 3, Issue 1, 60-73. 
26. Miller LA, Wert SE, Clark JC, et al. (2004) Role of Sonic hedgehog in patterning of 
tracheal-bronchial cartilage and the peripheral lung. Dev Dyn 231: 57-71. 
27. Motoyama J, Liu J, Mo R, et al. (1998) Essential function of Gli2 and Gli3 in the formation of 
lung, trachea and oesophagus. Nature Genetics 20: 54-57. 
28. Thomas HM, Todd PJ, Heaf D, et al. (1994) Recurrence of Pallister-Hall syndrome in two sibs. 
J Med Genet 31: 145-147. 
29. Zakin L, Metzinger CA, Chang EY, et al. (2008) Development of the vertebral morphogenetic 
field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. Dev Biol 323: 
6-18. 
30. Sala FG, Del Moral PM, Tiozzo C, et al. (2011) FGF10 controls the patterning of the tracheal 
cartilage rings via Shh. Development 138: 273-282. 
31. Rock JR, Futtner CR, Harfe BD (2008) The transmembrane protein TMEM16A is required for 
normal development of the murine trachea. Dev Biol 321: 141-149. 
32. Suemoto H, Muragaki Y, Nishioka K, et al. (2007) Trps1 regulates proliferation and apoptosis 
of chondrocytes through Stat3 signaling. Dev Biol 312: 572-581. 
33. Tiozzo C, De Langhe S, Carraro G, et al. (2009) Fibroblast Growth Factor 10 plays a causative 
role in the tracheal cartilage defects in a mouse model of Apert Syndrom. Paediatric Research 
66: 386-390. 
34. Elluru RG, Thompson F, Reece A (2009) Fibroblast growth factor 18 gives growth and 
directional cues to airway cartilage. Laryngoscope 119: 1153-1165. 
35. Regnier CH, Masson R, Kedinger V, et al. (2002) Impaired neural tube closure, axial skeleton 
malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad Sci USA 
99: 5585-5590. 
36. Hines EA, Jones MK, Verheyden JM, et al. (2013) Establishment of smooth muscle and 
cartilage juxtaposition in the developing mouse upper airways. Proc Natl Acad Sci USA 110: 
19444-19449. 
37. Pole RJ, Qi BQ, Beasley SW (2001) Abnormalities of the tracheal cartilage in the rat fetus with 
tracheo-oesophageal fistula or trachea agenesis. Peadiatric Surg Int 17: 25-28. 
38. Gonfiotti A, Jaus MO, Barale D, et al. (2013) The first tissue-engineered airway transplantation: 
5-year follow-up results. The Lancet 383: 238-244. 
© 2016 Karen J Liu et al., licensee AIMS Press. This is an open 
access article distributed under the terms of the Creative 
Commons Attribution License  
(http://creativecommons.org/licenses/by/4.0) 
